{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:01:51Z","timestamp":1780293711257,"version":"3.54.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116872","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:22:56Z","timestamp":1779355376000},"page":"116872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-\u03baB pathway and NLRP3 inflammasome-mediated pyroptosis"],"prefix":"10.1016","volume":"183","author":[{"given":"Qiang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.ajkd.2022.12.008","article-title":"Readmission and mortality after hospitalization with acute kidney injury","volume":"82","author":"Schulman","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2026.116872_bb0010","article-title":"Mechanisms and therapeutic prospects of hypoxia-inducible factor 1-alpha in acute kidney injury: a systematic review","volume":"13","author":"Kang","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"10212","key":"10.1016\/j.intimp.2026.116872_bb0015","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2026.116872_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ki.2012.20","article-title":"Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis","volume":"82","author":"Grgic","year":"2012","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2026.116872_bb0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41420-024-01843-5","article-title":"Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.116872_bb0035","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3389\/fimmu.2018.01900","article-title":"Inflammasomes in tissue damages and immune disorders after trauma","volume":"9","author":"Bortolotti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116872_bb0040","article-title":"NLRP3 inflammasome and inflammatory diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116872_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem. Sci."},{"issue":"7575","key":"10.1016\/j.intimp.2026.116872_bb0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2026.116872_bb0055","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1016\/j.celrep.2017.12.018","article-title":"The inflammasome drives GSDMD-independent secondary Pyroptosis and IL-1 release in the absence of Caspase-1 protease activity","volume":"21","author":"Schneider","year":"2017","journal-title":"Cell Rep."},{"issue":"7575","key":"10.1016\/j.intimp.2026.116872_bb0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2026.116872_bb0065","article-title":"Gasdermins: novel mitochondrial pore-forming proteins","volume":"6","author":"Rogers","year":"2019","journal-title":"Mol. Cell. Oncol."},{"issue":"7860","key":"10.1016\/j.intimp.2026.116872_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7150\/jca.77965","article-title":"Pyroptosis provides new strategies for the treatment of Cancer","volume":"14","author":"Jia","year":"2023","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.116872_bb0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116872_bb0090","first-page":"2847","article-title":"Methylene blue attenuates renal ischemia-reperfusion injury by negative regulation of NLRP3 signaling pathway","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2026.116872_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biocel.2018.02.015","article-title":"mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI","volume":"98","author":"Wen","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jep.2014.02.013","article-title":"The genus Anemarrhena Bunge: a review on ethnopharmacology, phytochemistry and pharmacology","volume":"153","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116872_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08923970903383889","article-title":"Inhibitory effects of steroidal timosaponins isolated from the rhizomes of Anemarrhena asphodeloides against passive cutaneous anaphylaxis reaction and pruritus","volume":"32","author":"Lee","year":"2010","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2026.116872_bb0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejphar.2014.06.013","article-title":"Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-\u03baB and MAPK pathways","volume":"740","author":"Jeong","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2026.116872_bb0115","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/cns.12697","article-title":"Sarsasapogenin-AA13 ameliorates a\u03b2-induced cognitive deficits via improving neuroglial capacity on a\u03b2 clearance and antiinflammation","volume":"23","author":"Huang","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2026.116872_bb0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bmcl.2016.11.070","article-title":"Synthesis and SAR study of novel sarsasapogenin derivatives as potent neuroprotective agents and NO production inhibitors","volume":"27","author":"Pan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.116872_bb0125","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2147\/DDDT.S256867","article-title":"Sarsasapogenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents lipopolysaccharide-induced bone loss in vivo","volume":"14","author":"Peng","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.116872_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27062032","article-title":"Chemistry, biosynthesis and pharmacology of Sarsasapogenin: a potential natural steroid molecule for new drug design, development and therapy","volume":"27","author":"Mustafa","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.intimp.2026.116872_bb0135","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ptr.6088","article-title":"Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats","volume":"32","author":"Liu","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.116872_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153314","article-title":"Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: in vivo and in vitro study","volume":"78","author":"Tang","year":"2020","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.intimp.2026.116872_bb0145","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.14336\/AD.2021.0318","article-title":"Targeting NLRP3 inflammasome in the treatment of diabetes and diabetic complications: role of natural compounds from herbal medicine","volume":"12","author":"Bai","year":"2021","journal-title":"Aging Dis."},{"issue":"7","key":"10.1016\/j.intimp.2026.116872_bb0150","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.fct.2009.04.009","article-title":"Anti-inflammatory effect of anemarsaponin B isolated from the rhizomes of Anemarrhena asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by negative regulation of the nuclear factor-kappaB and p38 pathways","volume":"47","author":"Kim","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116872_bb0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.intimp.2015.02.016","article-title":"Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-\u03baB and MAPK activation and restoring Th17\/Treg cell balance","volume":"25","author":"Lim","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116872_bb0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1142\/S0192415X16500415","article-title":"Timosaponin B-II ameliorates palmitate-induced insulin resistance and inflammation via IRS-1\/PI3K\/Akt and IKK\/NF-[formula: see text]B pathways","volume":"44","author":"Yuan","year":"2016","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.intimp.2026.116872_bb0165","first-page":"1","article-title":"Polystyrene Nanoplastics induce inflammasome activation in nasal epithelial cells via ROS-mediated mitochondrial dysfunction","author":"Kim","year":"2026","journal-title":"Environ. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116872_bb0170","first-page":"368","article-title":"Research progress of renal ischemia-reperfusion injury and mitochondrial dysfunction","volume":"42","author":"Zhang","year":"2022","journal-title":"Int. J. Urol. Nephrol."},{"key":"10.1016\/j.intimp.2026.116872_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.779432","article-title":"GSDMD mediates LPS-induced septic myocardial dysfunction by regulating ROS-dependent NLRP3 inflammasome activation","volume":"9","author":"Dai","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116872_bb0180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/08923973.2021.1955919","article-title":"Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress","volume":"43","author":"Mandlik","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2026.116872_bb0185","series-title":"Experimental Study of Chinese Medicine for Removing Blood Stasis and Detoxication Inhibiting Pyroptosis by Regulating NLRP3 Inflammasome Signaling Pathway [D]","author":"Liang","year":"2017"},{"issue":"9","key":"10.1016\/j.intimp.2026.116872_bb0190","first-page":"2037","article-title":"Anwulingnan improves learning and memory impairment and anti-apoptosic effect in D-galactose-induced mice","volume":"45","author":"Sun","year":"2024","journal-title":"Jilin Medical Journal."},{"key":"10.1016\/j.intimp.2026.116872_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107358","article-title":"NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages","volume":"92","author":"Shi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116872_bb0200","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1021\/acs.jmedchem.6b01624","article-title":"Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease","volume":"60","author":"Cocco","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116872_bb0205","first-page":"733","article-title":"Artesunate alleviates renal ischemia-reperfusion injury in rats by inhibiting pyroptosis via NLRP3 inflammasome","volume":"12","author":"Yuan","year":"2021","journal-title":"Organ Transplantation."},{"issue":"3","key":"10.1016\/j.intimp.2026.116872_bb0210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2353\/ajpath.2010.090594","article-title":"Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury","volume":"176","author":"Jiang","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2026.116872_bb0215","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3389\/fimmu.2020.01346","article-title":"Metabolic flexibility and innate immunity in renal ischemia reperfusion injury: the fine balance between adaptive repair and tissue degeneration","volume":"11","author":"Tammaro","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2026.116872_bb0225","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41419-019-1899-0","article-title":"Activation of BNIP3-mediated mitophagy protects against renal ischemia-reperfusion injury","volume":"10","author":"Tang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.116872_bb0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41419-024-06525-9","article-title":"CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury","volume":"15","author":"Ma","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.intimp.2026.116872_bb0235","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00109-023-02330-7","article-title":"Acid-sensing ion channel 1a exacerbates renal ischemia-reperfusion injury through the NF-\u03baB\/NLRP3 inflammasome pathway","volume":"101","author":"Yang","year":"2023","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.intimp.2026.116872_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1286546","article-title":"Acacetin inhibits inflammation by blocking MAPK\/NF-\u03baB pathways and NLRP3 inflammasome activation","volume":"15","author":"Bu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116872_bb0245","first-page":"1064","article-title":"Berberine inhibits H2O2-induced pyroptosis of macrophages through mtROS-NLRP3 pathway","volume":"38","author":"Su","year":"2022","journal-title":"Chin. J. Immunol."},{"key":"10.1016\/j.intimp.2026.116872_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.116872_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153521","article-title":"Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: implications for gout therapy","volume":"84","author":"Lin","year":"2021","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0260","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2025.2580730","article-title":"Nanotechnology-based targeted regulation of NLRP3 inflammasome: therapeutic strategies and clinical application prospects in inflammatory diseases","volume":"32","author":"Zhao","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2026.116872_bb0265","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fphys.2020.00906","article-title":"Tisp40 induces tubular epithelial cell GSDMD-mediated Pyroptosis in renal ischemia-reperfusion injury via NF-\u03baB Signaling","volume":"11","author":"Xiao","year":"2020","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116872_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111625","article-title":"Pyroptosis: a newly discovered therapeutic target for ischemia-reperfusion injury","volume":"12","author":"Zheng","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116872_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2026.116872_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114675","article-title":"Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3\u03b2 signaling pathway","volume":"192","author":"Li","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116872_bb0285","first-page":"17","article-title":"Zhimu saponin B-II reduces cerebral ischemia-reperfusion induced injury in rats by activating the cAMP\/PKA\/CREB pathway","volume":"26","author":"Liu","year":"2024","journal-title":"J. Hubei Univ. Chin. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:17:14Z","timestamp":1780291034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S1567576926007186"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116872","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarsasapogenin attenuates renal ischemia-reperfusion injury by inhibiting the NF-\u03baB pathway and NLRP3 inflammasome-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116872"}}